BACKGROUND: Early prognostication of long-term outcomes following ischemic stroke can facilitate medical decision-making. We hypothesized that the 24-hour National Institute of Health Stroke Scale (NIHSS) predicts 3-month clinical outcomes in anterior circulation stroke. METHODS: Secondary analyses of the Interventional Management of Stroke 3 (IMS3) and intravenous tissue plasminogen activator (IV tPA) for acute ischemic stroke [National Institute of Neurological Diseases and Stroke (NINDS) IV tPA] trials were performed. In participants with documented 24-hour NIHSS and 3-month Modified Rankin Scale (mRS), the predictive power of the 24-hour NIHSS and 24-hour NIHSS improvement for 3-month outcomes [mRS 0-2 and Barthel Index (BI) ≥95] was assessed. Percentages of good outcome (mRS 0-2 or BI ≥95) at 3, 6, and 12 months and mean quality of life (EQ5D™) index at 3 months across 24-hour NIHSS quartiles were compared. RESULTS: The majority of the study participants were included (IMS3 n = 587/656, NINDS IV tPA n = 619/624). The 24-hour NIHSS was correlated with 3-month mRS (R = 0.73) with excellent predictive power for mRS 0-2 [area under the curve (AUC) = 0.91] and BI ≥95 (AUC = 0.9) in both cohorts. A model with the 24-hour NIHSS alone correctly classified 82-84% of patients in both cohorts. The percentages of good outcomes at 3-12 months across 24-hour NIHSS quartiles were similar in both cohorts. mRS 0-2 was achieved by 75.6-77.7% of patients with 24-hour NIHSS ≤11 but by only 1.4-3.6% with 24-hour NIHSS ≥20. The EQ5D index at 3 months varied among NIHSS 0-4 (mean 0.86 ± 0.16), 5-11 (0.77 ± 0.18), and 12-19 (0.59 ± 0.26) quartiles. CONCLUSIONS: The 24-hour NIHSS strongly predicts long-term stroke outcomes and is associated with quality of life. Its easy availability, reliability, and validity support its use as an early prognostic marker and surrogate of clinical outcome in ischemic stroke.
RCT Entities:
BACKGROUND: Early prognostication of long-term outcomes following ischemic stroke can facilitate medical decision-making. We hypothesized that the 24-hour National Institute of Health Stroke Scale (NIHSS) predicts 3-month clinical outcomes in anterior circulation stroke. METHODS: Secondary analyses of the Interventional Management of Stroke 3 (IMS3) and intravenous tissue plasminogen activator (IV tPA) for acute ischemic stroke [National Institute of Neurological Diseases and Stroke (NINDS) IV tPA] trials were performed. In participants with documented 24-hour NIHSS and 3-month Modified Rankin Scale (mRS), the predictive power of the 24-hour NIHSS and 24-hour NIHSS improvement for 3-month outcomes [mRS 0-2 and Barthel Index (BI) ≥95] was assessed. Percentages of good outcome (mRS 0-2 or BI ≥95) at 3, 6, and 12 months and mean quality of life (EQ5D™) index at 3 months across 24-hour NIHSS quartiles were compared. RESULTS: The majority of the study participants were included (IMS3 n = 587/656, NINDS IV tPA n = 619/624). The 24-hour NIHSS was correlated with 3-month mRS (R = 0.73) with excellent predictive power for mRS 0-2 [area under the curve (AUC) = 0.91] and BI ≥95 (AUC = 0.9) in both cohorts. A model with the 24-hour NIHSS alone correctly classified 82-84% of patients in both cohorts. The percentages of good outcomes at 3-12 months across 24-hour NIHSS quartiles were similar in both cohorts. mRS 0-2 was achieved by 75.6-77.7% of patients with 24-hour NIHSS ≤11 but by only 1.4-3.6% with 24-hour NIHSS ≥20. The EQ5D index at 3 months varied among NIHSS 0-4 (mean 0.86 ± 0.16), 5-11 (0.77 ± 0.18), and 12-19 (0.59 ± 0.26) quartiles. CONCLUSIONS: The 24-hour NIHSS strongly predicts long-term stroke outcomes and is associated with quality of life. Its easy availability, reliability, and validity support its use as an early prognostic marker and surrogate of clinical outcome in ischemic stroke.
Entities:
Keywords:
Clinical examination; Ischemic stroke; National Institute of Neurological Diseases and Stroke; Outcome; Prognosis
Authors: Maarten Uyttenboogaart; Roy E Stewart; Patrick C A J Vroomen; Jacques De Keyser; Gert-Jan Luijckx Journal: Stroke Date: 2005-08-04 Impact factor: 7.914
Authors: Joseph P Broderick; Yuko Y Palesch; Andrew M Demchuk; Sharon D Yeatts; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Frank L Silver; Rüdiger von Kummer; Carlos A Molina; Bart M Demaerschalk; Ronald Budzik; Wayne M Clark; Osama O Zaidat; Tim W Malisch; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Renée H Martin; Lydia D Foster; Thomas A Tomsick Journal: N Engl J Med Date: 2013-02-07 Impact factor: 91.245
Authors: Ronald M Lazar; Brandon Minzer; Daniel Antoniello; Joanne R Festa; John W Krakauer; Randolph S Marshall Journal: Stroke Date: 2010-06-10 Impact factor: 7.914
Authors: Eva A Mistry; Sharon D Yeatts; Pooja Khatri; Akshitkumar M Mistry; Michelle Detry; Kert Viele; Frank E Harrell; Roger J Lewis Journal: Stroke Date: 2022-01-11 Impact factor: 7.914
Authors: Sudha Xirasagar; Yuqi Wu; Khosrow Heidari; Jiera Zhou; Meng-Han Tsai; James W Hardin; Robert Wronski; Dana Hurley; Edward C Jauch; Souvik Sen Journal: J Gen Intern Med Date: 2020-08-31 Impact factor: 5.128
Authors: Laura Heitsch; Laura Ibanez; Caty Carrera; Michael M Binkley; Daniel Strbian; Turgut Tatlisumak; Alejandro Bustamante; Marc Ribó; Carlos Molina; Antoni Dávalos; Elena López-Cancio; Lucia Muñoz-Narbona; Carol Soriano-Tárraga; Eva Giralt-Steinhauer; Victor Obach; Agnieszka Slowik; Joanna Pera; Katarzyna Lapicka-Bodzioch; Justyna Derbisz; Tomás Sobrino; José Castillo; Francisco Campos; Emilio Rodríguez-Castro; Susana Arias-Rivas; Tomas Segura; Gemma Serrano-Heras; Cristófol Vives-Bauza; Rosa Díaz-Navarro; Silva Tur; Carmen Jimenez; Joan Martí-Fàbregas; Raquel Delgado-Mederos; Juan Arenillas; Jerzy Krupinski; Natalia Cullell; Nuria P Torres-Aguila; Elena Muiño; Jara Cárcel-Márquez; Francisco Moniche; Juan A Cabezas; Andria L Ford; Rajat Dhar; Jaume Roquer; Pooja Khatri; Jordi Jiménez-Conde; Israel Fernandez-Cadenas; Joan Montaner; Jonathan Rosand; Carlos Cruchaga; Jin-Moo Lee Journal: Stroke Date: 2020-12-15 Impact factor: 7.914
Authors: Per Winkel; Philip M Bath; Christian Gluud; Jane Lindschou; H Bart van der Worp; Malcolm R Macleod; Istvan Szabo; Isabelle Durand-Zaleski; Stefan Schwab Journal: Trials Date: 2017-11-29 Impact factor: 2.279
Authors: Vicky Chalos; Nadinda A M van der Ende; Hester F Lingsma; Maxim J H L Mulder; Esmee Venema; Simone A Dijkland; Olvert A Berkhemer; Albert J Yoo; Joseph P Broderick; Yuko Y Palesch; Sharon D Yeatts; Yvo B W E M Roos; Robert J van Oostenbrugge; Wim H van Zwam; Charles B L M Majoie; Aad van der Lugt; Bob Roozenbeek; Diederik W J Dippel Journal: Stroke Date: 2019-12-04 Impact factor: 7.914